Flexeril: Effective Relief for Acute Muscle Spasms
| Product dosage: 15mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.86 | $57.26 (0%) | 🛒 Add to cart |
| 30 | $2.71 | $85.89 $81.37 (5%) | 🛒 Add to cart |
| 60 | $2.14 | $171.77 $128.58 (25%) | 🛒 Add to cart |
| 90 | $2.01 | $257.66 $180.82 (30%) | 🛒 Add to cart |
| 120 | $1.96 | $343.55 $235.06 (32%) | 🛒 Add to cart |
| 180 | $1.91 | $515.32 $343.55 (33%) | 🛒 Add to cart |
| 270 | $1.86 | $772.99 $501.26 (35%) | 🛒 Add to cart |
| 360 | $1.81
Best per pill | $1030.65 $650.94 (37%) | 🛒 Add to cart |
Flexeril (cyclobenzaprine hydrochloride) is a centrally acting skeletal muscle relaxant indicated as an adjunct to rest and physical therapy for the relief of muscle spasm associated with acute, painful musculoskeletal conditions. It works by acting primarily within the central nervous system at the brainstem to reduce tonic somatic motor activity, influencing both gamma and alpha motor neurons. Clinical studies demonstrate that Flexeril helps relieve muscle spasm local pain and tenderness, thereby increasing range of motion. It is intended for short-term use (up to two or three weeks) due to insufficient evidence of effectiveness for longer periods and because muscle spasm associated with acute musculoskeletal conditions is generally transient.
Features
- Active ingredient: Cyclobenzaprine HCl
- Available in 5 mg and 7.5 mg oral tablets
- Rapid onset of action, typically within one hour
- FDA-approved for acute musculoskeletal conditions
- Short-term therapy protocol (2-3 weeks maximum)
- Central nervous system-mediated mechanism of action
Benefits
- Provides rapid relief from acute muscle spasms and associated discomfort
- Reduces local pain and tenderness, facilitating improved mobility
- Enhances the effectiveness of physical therapy and rest protocols
- Helps restore normal muscle function and range of motion
- Minimizes interference with activities of daily living during recovery
- Supports comprehensive treatment plans for musculoskeletal injuries
Common use
Flexeril is commonly prescribed for the management of muscle spasms associated with acute, painful musculoskeletal conditions such as strains, sprains, and other muscle injuries. It is typically used when rest alone is insufficient and serves as an adjunct to physical therapy. Healthcare providers may prescribe Flexeril for conditions including back pain, neck pain, and other musculoskeletal disorders where muscle spasm contributes significantly to discomfort and functional limitation. The medication is specifically indicated for short-term use, generally not exceeding three weeks, as most acute musculoskeletal conditions resolve within this timeframe.
Dosage and direction
The recommended dosage of Flexeril for most adults is 5 mg three times daily. Based on individual patient response and tolerance, the dosage may be increased to 7.5 mg or 10 mg three times daily. Tablets should be swallowed whole with water and may be taken with or without food. The maximum recommended daily dose is 30 mg (divided into three doses). For elderly patients and those with hepatic impairment, a lower starting dose of 5 mg is recommended. Treatment should not exceed two or three weeks due to lack of evidence supporting longer-term efficacy. Always follow the specific dosing instructions provided by your healthcare provider.
Precautions
Patients should use caution when operating machinery or driving as Flexeril may cause drowsiness or dizziness. Alcohol consumption should be avoided as it may enhance these effects. The medication should be used with caution in patients with mild to moderate hepatic impairment and is not recommended in severe hepatic impairment. Elderly patients may be more sensitive to the effects of Flexeril, particularly regarding anticholinergic effects. Patients should inform their healthcare provider if they have a history of urinary retention, angle-closure glaucoma, increased intraocular pressure, or thyroid disorders. Abrupt discontinuation after prolonged use should be avoided.
Contraindications
Flexeril is contraindicated in patients hypersensitive to cyclobenzaprine or any component of the formulation. It should not be used concomitantly with monoamine oxidase (MAO) inhibitors or within 14 days after their discontinuation. Additional contraindications include hyperthyroidism, recent myocardial infarction, cardiac arrhythmias including heart block, conduction disturbances, or congestive heart failure. The medication is contraindicated in patients with severe hepatic impairment. Flexeril should not be used in the recovery phase of myocardial infarction.
Possible side effect
Common side effects include drowsiness (occurring in approximately 39% of patients), dry mouth (27%), and dizziness (11%). Less frequent side effects may include fatigue, nausea, constipation, dyspepsia, and blurred vision. Some patients may experience nervousness or confusion. Uncommon but serious side effects requiring immediate medical attention include tachycardia, arrhythmias, syncope, severe allergic reactions, and signs of serotonin syndrome (agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea). Most side effects are dose-related and may diminish with continued therapy.
Drug interaction
Flexeril may interact significantly with MAO inhibitors, potentially leading to serious reactions including hyperpyretic crisis, severe convulsions, and death. It may enhance the effects of alcohol, barbiturates, and other CNS depressants. Concurrent use with anticholinergic medications may result in additive effects. Flexeril may interact with tramadol, increasing seizure risk. The medication may enhance the effects of norepinephrine, phenylephrine, and other sympathomimetics. Use with tricyclic antidepressants may increase the risk of serotonin syndrome. Patients should inform healthcare providers of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent blood levels is important for optimal effectiveness, but occasional missed doses are unlikely to cause significant problems given Flexeril’s relatively short half-life. Patients should contact their healthcare provider if multiple doses are missed or if they have questions about proper dosing.
Overdose
Symptoms of Flexeril overdose may include severe drowsiness, tachycardia, tremor, agitation, confusion, hallucinations, and cardiac arrhythmias. Severe overdose may lead to coma, cardiac arrest, and death. Management involves gastric lavage if presentation is early, followed by activated charcoal. Treatment is primarily supportive and symptomatic, with careful cardiac monitoring. Physostigmine may be considered for serious central anticholinergic effects. Dialysis is unlikely to be beneficial due to Flexeril’s high protein binding and extensive tissue distribution. Any suspected overdose requires immediate medical attention.
Storage
Store Flexeril tablets at controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the medication in its original container, tightly closed, and protected from light and moisture. Store out of reach of children and pets. Do not transfer tablets to other containers. Properly discard any expired or unused medication through medication take-back programs or according to FDA-recommended disposal methods. Do not flush medications down the toilet unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Flexeril is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual response to medication may vary, and only your healthcare provider can determine the appropriate treatment for your specific condition. This information does not cover all possible uses, directions, precautions, or interactions. Always consult with your healthcare provider before starting, stopping, or changing any medication regimen.
Reviews
Clinical studies demonstrate that Flexeril provides significantly greater relief of muscle spasm than placebo, with improvement often noted within the first few days of treatment. Many patients report reduced pain and improved mobility when used as part of a comprehensive treatment plan including rest and physical therapy. Some users note drowsiness as a limiting factor, particularly during initial treatment. Healthcare providers generally consider Flexeril effective for short-term management of acute musculoskeletal conditions when used appropriately according to prescribing guidelines. Patient experiences vary, and individual response should be monitored closely by healthcare professionals.